Wilex AG?is a biopharmaceutical company and develops drugs based on antibodies and small molecules with a low side effect profile and targeted treatment of different types of cancer as well as diagnostic agents for specific detection of tumors. The company’s aim is to help oncologists administer targeted treatments to carefully diagnosed patients and to enhance patients’ health related Quality of Life (hrQoL).
Since its formation Wilex has focused its activities on oncology, pursuing the development of new cancer therapies to enable efficacious well-tolerated treatments. ?Over the years, the business model has been expanded to include new technologies intended to raise the company’s profile in oncology and improve its competitive position.
Today Wilex offers a combined portfolio of both therapeutics and diagnostics. Its aim is to help oncologists and other specialists administer targeted treatments to carefully diagnosed patients and offer therapy options tailored to different types and stages of cancer.
Grillparzerstr. 10
81675 Munich
Germany
Web: Wilex AG
